Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.34% inched 0.22% higher to $164.08 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.01% rising 0.47% to 4,566.48 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.53% rising 0.18% to 35,741.15. This was the stock's second consecutive day of gains. Johnson & Johnson closed $15.84 short of its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.60% rose 1.51% to $389.88, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.82% rose 0.63% to $81.66, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -2.13% fell 0.02% to $43.15. Trading volume (6.7 M) eclipsed its 50-day average volume of 6.0 M.